You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Overview

Properties

Applications

Our Abpromise guarantee covers the use of ab110691 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Notes
WB WB: Use a concentration of 1 µg/ml. Predicted molecular weight: 34 kDa. Good results were obtained when blocked with 5% non-fat dry milk in 0.05% PBS-T.

Target

  • FunctionMinor apolipoprotein that associates with LDL. Inhibits cholesteryl ester transfer protein (CETP) activity and appears to be an important regulator of cholesterol transport. Also associates to a lesser degree with VLDL, Apo-AI and Apo-AII.
  • Tissue specificityExpressed by the liver and secreted in plasma.
  • Cellular localizationSecreted.
  • Target information above from: UniProt accession Q13790 The UniProt Consortium
    The Universal Protein Resource (UniProt) in 2010
    Nucleic Acids Res. 38:D142-D148 (2010) .

    Information by UniProt
  • Database links
  • Alternative names
      Apo-F antibodyApoF antibodyAPOF_HUMAN antibody
      Apolipoprotein F antibodyDKFZp781G18150 antibodyLipid transfer inhibitor protein antibodyLTIP antibodyMGC22520 antibody
    see all

Anti-Apolipoprotein F antibody images

  • Anti-Apolipoprotein F antibody (ab110691) at 1 µg/ml + Rat Kidney lysate at 10 µg

    Predicted band size : 34 kDa

References for Anti-Apolipoprotein F antibody (ab110691)

ab110691 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab110691.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"